Publication

Virtual technologies accelerate development of drug delivery devices

Companies are exploiting all the power of those technologies to gain the competitive edge that is so critical to their survival - or are they? Many companies have failed to realise the full commercial benefits of these tools. However, PA Consulting Group's recent development of a breath-actuated inhaler has demonstrated how time to market can be reduced to a third of what would be regarded as the industry norm.

When PA embarked on the development of a new breath-actuated inhaler, best practice use of computer-aided engineering and rapid prototyping techniques were core to the development plan. What PA regards as best practice has been developed from the experience of numerous projects in the drug delivery sector and from the other areas in which it operates.